Inhibition of cancer growth by inhibition of PCK1 or PCK2 has been shown in different tumor models in vivo, including xenografts of lung cancer, prostate cancer and colon cancer [71,73,74,77,78,81]. Here, PCK2 is linked to neoplasm.